Sort
82,697 grants matching “vaccine development”
Modulation of the early host response to SIV in pathogenic infection
$798,123Amitinder Kaur · Harvard Medical School · R01 · FY2011 · AI
Development of a nanoemulsion-adjuvanted prophylactic HSV-2 vaccine
$798,081Ali I. Fattom · Bluewillow Biologics, Inc. · R44 · FY2017 · AI
Early and Reinfection in High Risk Women
$798,075Julie M Overbaugh · Fred Hutchinson Cancer Research Center · R37 · FY2015 · AI
Immunosurveillance of breast glands with oncogenic germline mutations
$797,986Shadmehr Demehri · Massachusetts General Hospital · UG3 · FY2025 · CA
Immunosurveillance of breast glands with oncogenic germline mutations
$797,986Shadmehr Demehri · Massachusetts General Hospital · UG3 · FY2024 · CA
AUTOIMMUNITY--MECHANISMS OF UNRESPONSIVENESS
$797,914Stanford University · P01 · FY2001 · AI
Liver resident memory for malaria
$797,863Sean C Murphy · University Of Washington · R01 · FY2021 · AI
Project 1: Pharmacokinetics of Combination Antiretroviral Intravaginal Rings
$797,832Craig Walter Hendrix · Oak Crest Institute Of Science · U19 · FY2018 · AI
Combining Molecular Simulations and Biophysical Methods to Characterize Conformational Dynamics of the HIV-1 Envelope Glycoprotein
$797,785Cameron F Abrams · Drexel University · R01 · FY2024 · AI
TISSUE BIOSPECIMEN AND PATHOLOGY RESOURCE
$797,780Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P30 · FY2014 · CA
T cell Immunity and the Outcome of Acute HCV Infection
$797,768Christopher M. Walker · Research Inst Nationwide Children'S Hosp · R01 · FY2016 · AI
Prevention of Graft-Versus-Host-Disease in the Era of Adoptive Immunotherapy
$797,767Marie Bleakley · Fred Hutchinson Cancer Research Center · P01 · FY2019 · CA
Decoding mechanisms of early life inflammation
$797,735Shruti Naik · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AI
Vaccine Development Of Nontypeable Haemophilus influenzae/Moraxella catarrhalis
$797,700Xin-Xing Xing Gu · National Institute On Deafness And Other Communication Disorders · Z01 · FY2008 · DC
Western States Node of the National Drug Abuse Treatment Clinical Trials Network
$797,698James L. Sorensen · University Of California, San Francisco · UG1 · FY2019 · DA
PROTECTIVE MECHANISMS WITH ATTENUATED LENTIVIRAL VACCINE
$797,663University Of California Davis · R01 · FY2002 · AI
Hepatitis C: Studies of Immunity and Pathogenesis
$797,618Charles M. Rice · Rockefeller University · U19 · FY2008 · AI
Controlled Infection Trial to Test Efficacy of Hookworm Vaccine with Different TLR Agonists
$797,494David Joseph Diemert · George Washington University · U01 · FY2017 · AI
Immune epigenetic biomarkers of survival in glioma epidemiology
$797,441John K. Wiencke · University Of California, San Francisco · R01 · FY2020 · CA
Modeling immune impairments and pathogenesis in novel humanized mice for HBV-HIV co-infection
$797,362Lishan Su · Univ Of North Carolina Chapel Hill · R01 · FY2018 · AI
Influence of viral and immune interventions on early events following oral SIV infection
$797,333Donald L Sodora · Seattle Children'S Hospital · R01 · FY2025 · DE
RP1: rVSV Vectored Vaccine to Treat Ebola and Marburg Infection
$797,292John H Eldridge · University Of Texas Med Br Galveston · U19 · FY2015 · AI
Discovery and Targeting of West Nile Virus Epitopes
$797,240William Hildebrand · University Of Oklahoma Hlth Sciences Ctr · U01 · FY2009 · AI
Overcoming humoral rejection after xenotransplantation in sensitized nonhuman primate recipients
$797,199Jean Kwun · Duke University · R01 · FY2024 · AI
A risk-varying and perturbed self-controlled case series design for assessing the safety of COVID-19 vaccines in a large health care system
$797,195Stanley Xu · Kaiser Foundation Research Institute · R01 · FY2024 · AI